Page 5 - Best Chemotherapy Chemotherapy: TOP 156 doctors

Forbes named Dr. Tabernero one of Spain's 5 most influential cancer leaders. Former President of the European Society for Medical Oncology.

• Director of the Vall d’Hebrón Institute of Oncology
• Specializes in molecular targeted therapies and personalized cancer treatments
• Author of over 70 papers on innovative cancer treatments
• Conducts clinical trials for new colon cancer therapies

Assoc. Prof. Atakan Topcu specializes in solid tumors and cancer-related conditions, bringing extensive expertise in targeted therapies and immunotherapy.

• Published over 50 scientific articles in oncology
• Member of ESMO and Turkish Society of Medical Oncology
• Focuses on geriatric oncology and cancer-related malnutrition
• Fellowship-trained in Medical Oncology at Bezmialem Vakıf University

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – a leading institution in Turkey.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Works at Medical Park Antalya Hospital Complex
• Member of the Turkish Medical Association

Assoc. Prof. Ayse Irem Yasin specializes vergewis in medical oncology with extensive experience treating various cancers at Medipol Acibadem District Hospital.

• Board-certified in medical oncology with ESMO certification
• Specializes in breast, lung, and gastrointestinal cancers
• Trained internationally at prestigious institutions like Cleveland Clinic and Harvard Medical School
• Completed fellowship in medical oncology at Bezmialem Vakif University

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Clinical Director of a Multidisciplinary Breast Unit with 322 peer-reviewed publications – Dr. Kuemmel leads breast cancer research at Kliniken Essen-Mitte.

• Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
• ESMO Faculty member for Breast Cancer
• Global PI and head of 27 clinical investigations and trials
• Member of multiple prestigious oncology societies including ESMO and ASCO

Associate Professor Muhammed Mustafa Atci leads the Medical Oncology program at İstinye University Liv Hospital Topkapı, with extensive research in chemotherapy outcomes.

• Specializes in medical oncology with a focus on chemotherapy protocols
• Published multiple studies on chemotherapy efficacy in peer-reviewed journals
• Member of the American Society of Clinical Oncology (ASCO)
• Education Coordinator for Medical Oncology Sub-Branch

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Ivetta Danylesko specializes in chemotherapy at Sheba Medical Center, bringing expert care tailored to individual patient needs.

• Specializes in chemotherapy protocols
• Practices at Sheba Medical Center, a top-tier facility
• Focuses on personalized treatment approaches

Dr. Prat leads SOLTI as president, designing clinical trials for breast cancer treatments. His research focuses on gene expression and molecular subtypes.

• Head of Translational Genomics and Targeted Therapeutics at IDIBAPS
• Co-founder of Reveal Genomics, holds three patents
• Over 160 publications with an H-Index of 51
• Medical oncology fellowship at Vall d´Hebron Institute of Oncology
• Tenure-Track Professor at Barcelona University

Dr. Graus is a leading expert in paraneoplastic neurological syndromes, having defined the first strict diagnostic criteria for these conditions.

• 44 years of experience of experience in neuro-oncology
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Specializes in neurotoxicities from cancer treatments
• Honorary doctorate from Lyon University

Specialized in gynecological oncology and chemotherapy at Samsung Medical Center.

• Focused expertise in gynecological cancers and chemotherapy treatments
• Works at Samsung Medical Center, a leading healthcare institution
• Oncogynecologist with a strong background in women's cancer care

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Fellowship-trained in lung cancer at University of Colorado Denver
• Received MERIT award from American Society of Clinical Oncology (ASCO)
• Chairs IASLC's Early Detection & Prevention Committee
• Specializes in personalized medicine and immuno-oncology for lung cancer

With over 20 years of oncology expertise, Dr. Lucía González Cortijo leads Quironsalud Madrid's oncology department and specializes in breast and gynecologic cancers.

• Focuses on personalized treatments, including immunotherapy and targeted therapies
• Principal investigator in 20+ clinical trials for breast cancer
• Member of ESMO, ASCO, and GEICAM research groups
• Founder of 'Corre en Rosa' to support cancer patients through physical activity
• Trained at MD Anderson Cancer Center Madrid

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.